# catalytic_activity_0084

[All 1,736 questions](../README.md) · [Method and limits](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `catalytic_activity`  
**Author expected answer:** **B** — okaramine C + 2 reduced &#91;NADPH--hemoprotein reductase&#93; + 2 O2 = okaramine A + 2 oxidized &#91;NADPH--hemoprotein reductase&#93; + 4 H2O + 2 H(+)

| Expected-answer support | Reasoning versus lookup | Review status |
|---|---|---|
| supported | reasoning-supported | format-valid AI review |

These labels are Luna’s original judgments. Source support and reasoning from the original input are separate questions. The benchmark key and original score are unchanged.

## Complete original question

The sequence and choices below are the complete original user message, in their original order.

```text
[Protein Sequence]
MASEIYRRLPMELPAQHLLASLALVGALLSVGYLLLRPAKYQLPLPPGPRGLPIIGNLHQAPKEKAWEVYKQWSDRYGPIMSVNNGGMITIIVSSHEVVKNFLEKNNAVFSSRPQLLVLERALYGFTTPALPYGEKWLKHRALRGAVLKPAMAVRYRGLQDLESKQLLRDLLYSEDFTQCMRRQAASLFLGIAYGNRFPEETPEIIDIDQAVAQLGGISESMFQGTGMLREFFPVLKYFPGYDKFLKQLDDVGERLANIYVRRFRDGLSTPAWNWAKEYSKRPEAQGMGELELSFCIGSTYQASLTPYEILRIILLAAICHPEEKARLQKEIDLVVGKDNLPGWEHKDRIQFVQAFIYEALRWHAFSPLGAPRAVSRDIEYKGYFIPKGATLVLNQWAMDHDENVYDNPFTFRPQRWIDNPDLPHVIFGFGLRGCPGQHLARDHLFINTARLFWAFNFGNAYENGKKVELDLDELMQPRGGGSAFNQVPSFKASVIIRSSERRQIVENEWDAVEKDEQKILAEAMPLPE

[Multiple Choices]
A. an alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphospho-di-trans,poly-cis-dolichol + a di-trans,poly-cis-dolichyl beta-D-mannosyl phosphate = an alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphospho-di-trans,poly-cis-dolichol + a di-trans,poly-cis-dolichyl phosphate + H(+)
B. okaramine C + 2 reduced [NADPH--hemoprotein reductase] + 2 O2 = okaramine A + 2 oxidized [NADPH--hemoprotein reductase] + 4 H2O + 2 H(+)
C. 17-O-acetylnorajmaline + H2O = norajmaline + acetate + H(+)
D. 2'-hydroxy-2-oxospirilloxanthin + 2 reduced [2Fe-2S]-[ferredoxin] + O2 + 2 H(+) = 2',2'-dihydroxy-2-oxospirilloxanthin + 2 oxidized [2Fe-2S]-[ferredoxin] + H2O
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzymatic Reaction Prediction, which is to identify the specific chemical reaction catalyzed by a given enzyme. This involves understanding the enzyme's function based on its amino acid sequence and then selecting the correct transformation of substrates into products from a list of possible reactions.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Luna’s full visible review

### Expected-answer support: supported

> The supplied sequence exactly matches the UniProt entry for cytochrome P450 monooxygenase okaD. That entry annotates the okaramine C-to-A reaction and cites experimental evidence (ECO:0000269, PubMed 28631282), supporting choice B.

Cited evidence: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a recognizable P450 heme-binding motif (around FGFGLRGCPG), and choice B is the option with NADPH-reductase-supported P450 monooxygenation chemistry. That provides a concrete family-level basis to distinguish B from the glycosylation, hydrolysis, and 2Fe-2S-dependent alternatives.

**Missing item-specific fact**

> The motif does not itself establish okaramine C as the substrate or okaramine A as the product; those exact substrate and product identities are protein-specific.

**Reason**

> The sequence and choices provide meaningful grounds for selecting the P450-compatible reaction, although the exact transformation is not derivable from the motif alone.

### Question ambiguity

**Multiple defensible options named by Luna:** none.

> Among the listed reactions, B is the one consistent with the sequence's P450-family signal; the alternatives describe different enzyme classes or cofactor chemistry.

### Important caveats

- The sequence match is exact in both the current and historical UniProt records, but the author's source snapshot is unknown.
- The cited experimental evidence is reported in the UniProt annotation; the primary study was not independently retrieved or assessed here.
- Family-level sequence evidence supports choosing B among these options but does not independently establish its precise okaramine substrate and product.

<details>
<summary>Saved visible review as JSON</summary>

```json
{
  "case_id": "catalytic_activity_0084",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the UniProt entry for cytochrome P450 monooxygenase okaD. That entry annotates the okaramine C-to-A reaction and cites experimental evidence (ECO:0000269, PubMed 28631282), supporting choice B.",
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H4"
    ]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a recognizable P450 heme-binding motif (around FGFGLRGCPG), and choice B is the option with NADPH-reductase-supported P450 monooxygenation chemistry. That provides a concrete family-level basis to distinguish B from the glycosylation, hydrolysis, and 2Fe-2S-dependent alternatives.",
    "missing_item_specific_fact": "The motif does not itself establish okaramine C as the substrate or okaramine A as the product; those exact substrate and product identities are protein-specific.",
    "reason": "The sequence and choices provide meaningful grounds for selecting the P450-compatible reaction, although the exact transformation is not derivable from the motif alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed reactions, B is the one consistent with the sequence's P450-family signal; the alternatives describe different enzyme classes or cofactor chemistry."
  },
  "important_caveats": [
    "The sequence match is exact in both the current and historical UniProt records, but the author's source snapshot is unknown.",
    "The cited experimental evidence is reported in the UniProt annotation; the primary study was not independently retrieved or assessed here.",
    "Family-level sequence evidence supports choosing B among these options but does not independently establish its precise okaramine substrate and product."
  ]
}
```

</details>

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**This source material was supplied only to the reviewer. It was absent from the original evaluated question.** An exact-sequence database match can support a key without establishing that the question can be answered by reasoning from its original input.

**Accession:** `A0A2Z5U6I9`; identity was recovered from dataset image-path metadata and was absent from the evaluated model input.  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; selected entry version 23. The exact author source snapshot remains unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2Z5U6I9.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:54.111891+00:00.  

```json
"A0A2Z5U6I9"
```

Source SHA-256: `40a05d7310f4d79d3d8cc83398d816d9e515e9003ac315147b668ca6050d9c84`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2Z5U6I9.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:54.111891+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"28631282","source":"PubMed"}],"value":"Okaramines biosynthesis cluster protein D"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"28631282","source":"PubMed"}],"value":"1.14.99.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"28631282","source":"PubMed"}],"value":"Cytochrome P450 monooxygenase okaD"}}}
```

Source SHA-256: `40a05d7310f4d79d3d8cc83398d816d9e515e9003ac315147b668ca6050d9c84`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2Z5U6I9.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:54.111891+00:00.  

```json
{"commentType":"CATALYTIC ACTIVITY","physiologicalReactions":[{"directionType":"left-to-right","evidences":[{"evidenceCode":"ECO:0000269","id":"28631282","source":"PubMed"}],"reactionCrossReference":{"database":"Rhea","id":"RHEA:82704"}}],"reaction":{"evidences":[{"evidenceCode":"ECO:0000269","id":"28631282","source":"PubMed"}],"name":"okaramine C + 2 reduced [NADPH--hemoprotein reductase] + 2 O2 = okaramine A + 2 oxidized [NADPH--hemoprotein reductase] + 4 H2O + 2 H(+)","reactionCrossReferences":[{"database":"Rhea","id":"RHEA:82703"},{"database":"Rhea","id":"RHEA-COMP:11964"},{"database":"Rhea","id":"RHEA-COMP:11965"},{"database":"ChEBI","id":"CHEBI:15377"},{"database":"ChEBI","id":"CHEBI:15378"},{"database":"ChEBI","id":"CHEBI:15379"},{"database":"ChEBI","id":"CHEBI:57618"},{"database":"ChEBI","id":"CHEBI:58210"},{"database":"ChEBI","id":"CHEBI:193028"},{"database":"ChEBI","id":"CHEBI:232464"}]}}
```

Source SHA-256: `40a05d7310f4d79d3d8cc83398d816d9e515e9003ac315147b668ca6050d9c84`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A2Z5U6I9?format=txt&versions=23)  
**Locator:** `lines 58-66`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 23 / 1.  
**Retrieved:** 2026-11-02T04:24:57.209412+00:00.  

```text
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=okaramine C + 2 reduced [NADPH--hemoprotein reductase] + 2 O2
CC         = okaramine A + 2 oxidized [NADPH--hemoprotein reductase] + 4 H2O + 2
CC         H(+); Xref=Rhea:RHEA:82703, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:193028,
CC         ChEBI:CHEBI:232464; Evidence={ECO:0000269|PubMed:28631282};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:82704;
CC         Evidence={ECO:0000269|PubMed:28631282};
```

Source SHA-256: `325b1f9f1545fcf13c71c1f0abd0af2223be88dff7649f9a3b61a997d58cc16f`.

---

Question and key: [LiveProteinBench source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/catalytic_activity.json) (zero-based source row 84). Benchmark content © 2026 LiveProteinBench contributors, [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). Cited UniProt / Gene Ontology excerpts retain their own attribution; see [source credits](../THIRD_PARTY_NOTICES.md).
